BIHALE ROTACAP

Vilanterol Trifenatate INN & Fluticasone Furoate BP

Respiratory

 
 
 
 
 


Indication

Bihale Rotacap is indicated for-

  • Treatment of Asthma in patient aged 12 years and older
  • Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD)

Bihale Rotacap is not indicated for the relief of Acute Bronchospasm.


Dosage and Administration

Route of administration: For oral inhalation only.
The capsule is to be inserted into the ACME’s Easyhaler device for use. So, the capsule will be pierced and ready to be used.

Special instruction: Bihale Rotacap should be used at the same time every day. Do not use Bihale Rotacap more than 1 time every 24 hours. After inhalation, the patient should rinse the mouth with water without swallowing to reduce the risk of oropharyngeal candidiasis.

Dosage:
Asthma: 1 Rotacap of Bihale 100/25 or Bihale 25/200 once daily.

Maintenance treatment of COPD: 1 Rotacap of Bihale 25/100 once daily.


Composition

Bihale 25/100 Rotacap: Each capsule contains Vilanterol 25 mcg as Vilanterol Trifenatate INN and Fluticasone Furoate BP 100 mcg
Bihale 25/200 Rotacap: Each capsule contains Vilanterol 25 mcg as Vilanterol Trifenatate INN and Fluticasone Furoate BP 200 mcg.